Last update 17 Jun 2025

MIDRIXNEO-LUNG DCs(Ghent University Hospital)

Overview

Basic Info

Drug Type
Therapeutic vaccine, Dendritic cell vaccine
Synonyms
MIDRIX4-LUNG
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Non-Small Cell Lung Cancer
Inactive Indication
metastatic non-small cell lung cancer
Originator Organization
Ghent University HospitalGhent University Hospital
Active Organization
Ghent University HospitalGhent University Hospital
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MIDRIXNEO-LUNG DCs(Ghent University Hospital)
NCT04082182
/ Unknown statusPhase 1IIT
Phase Ia Study of MIDRIX4-LUNG, a Tetravalent Autologous Dendritic Cell Vaccine, in Patients With Metastatic Non-small Cell Lung Cancer
100 Clinical Results associated with MIDRIXNEO-LUNG DCs(Ghent University Hospital)
Login to view more data
100 Translational Medicine associated with MIDRIXNEO-LUNG DCs(Ghent University Hospital)
Login to view more data
100 Patents (Medical) associated with MIDRIXNEO-LUNG DCs(Ghent University Hospital)
Login to view more data
100 Deals associated with MIDRIXNEO-LUNG DCs(Ghent University Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
metastatic non-small cell lung cancerPhase 1
Belgium
Ghent University HospitalGhent University Hospital
26 Aug 2019
Non-Small Cell Lung CancerPhase 1
Belgium
Ghent University HospitalGhent University Hospital
26 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04082182 (ESMO_ELCC2025)
ManualManual
Phase 1
metastatic non-small cell lung cancer
6
oicavogqyc(hewdhisrsx) = dizziness (N=3), fatigue (N=3), nausea (N=2) and flu-like symptoms (N=2). iggagdeujn (scsoikmvyc )
Positive
26 Mar 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free